Curaderm BEC5

acy rating. Curaderm BEC5 is recognized and clinically approved to regress sunspots, keratosis, basal cell carcinoma and squamous cell carcinomas.

“Dr. Cham has discovered, and then thoroughly researched and developed a near-perfect product for two common skin cancers. If anyone deserves a Nobel Prize in Medicine, it’s Dr. Bill E. Medical Director, Tahoma Clinic, Renton, Washington, USA

“People, like Dr Cham, are an endangered species in this day and age. On his own time, using his own money, he has developed a product that could benefit millions of people around the world. Curaderm is one of those rare gems I have been lucky enough to find in my research. With all the conventional therapies, scarring almost always results. This can be especially disturbing in facial cancers. In many cases, plastic surgery is necessary to reduce scarring and disfigurement. With Curaderm these problems don’t exist. The only cells affected are the cancer cells.” —Dr. David G Williams M.D. Editor: Alternatives

Since 1979 Curaderm-BEC5 has been performing ongoing research and clinical success with the the core technology which is a unique class of naturally occurring compounds.

*While non melanoma skin cancers both have a better than 95% cure rate, if detected and treated early, treatment is typically disfiguring.

*Specific endogenous endocytic lectins (EELs) were found to be present at much higher concentrations in cancer cells relative to normal cells.

*These EELs were present on the cell surface as receptors which recognized and bound the sugar moiety, in particular the rhamnose sugar (1990).

*BEC was subsequently internalized in the cancer cell and became lysosomotropic and consequently autolysis occurred.

*The disintegrated lysosome resulted in apoptosis of the affected cancer cells.

*BEC was also shown to induce cell apoptosis by modulating tissue necrosis factor (TNF) (2004). The products and information contained herein are not intended to diagnose, treat, cure, or prevent any diseases or, medical problems. It is not intended to replace your doctor's recommendations. The information is provided for educational purposes only. Benefits may vary from one person to another. Curaderm BEC5 is the only scientifically verified topical cream for the treatment of skin cancer. The cream works exceedingly well with non-melanoma skin cancers such as squamous cell and basal cell which are the common varieties. One advantage is that the cancer ‘melts away’ leaving normal skin with no scarring. Skin cancer involving the lip is an excellent case for the cream since surgery can be disfiguring, while the BEC5 skin cream allows a smoothly healed result. Non-melanoma skin cancer can be conveniently and effectively treated by Bec5 cream which is also known as Curaderm. Externally and topically applied, Curaderm cream is an eggplant skin cancer cure which is especially potent when applied to Basal cell carcinomas. Containing a specially purified plant extract, not only is Curaderm glycoalkaloid cream effective on Basal cell carcinomas ( BCC ) or Squamous cell carcinomas ( SCC ) – the most common forms of skin cancer - but Bec5 eggplant extract also works on benign tumours like sun spots, age spots, Keratoses and Keratocanthmoas. Derived from the plant Solanum Sodomaeum which is found in Australasia, the plant contains an important eggplant extract for skin cancer – Solasodine Glycosides – an active ingredient which is also found in smaller quantities in the eggplant and aubergine. Solasodine Glycosides has been found extremely effective in treating skin for cancerous conditions and is therefore incorporated into Bec 5 curaderm cream - a well known age spots cream and sun spot cream – to treat the effects and source of skin cancer.